Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2015, Article ID 970730, 10 pages
http://dx.doi.org/10.1155/2015/970730
Review Article

Efficacy of Adjunctive Treatments Added to Olanzapine or Clozapine for Weight Control in Patients with Schizophrenia: A Systematic Review and Meta-Analysis

Red Cross College of Nursing, Chung-Ang University, 84 Heukseok-Dong, Dongjak-Gu, Seoul 156-756, Republic of Korea

Received 16 July 2014; Revised 2 December 2014; Accepted 11 December 2014

Academic Editor: Dawn I. Velligan

Copyright © 2015 Yun-Jung Choi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [12 citations]

The following is the list of published articles that have cited the current article.

  • W. Zheng, Y.-T. Xiang, Y.-Q. Xiang, X.-B. Li, G. S. Ungvari, H. F. K. Chiu, and C. U. Correll, “Efficacy and safety of adjunctive topiramate for schizophrenia: a meta-analysis of randomized controlled trials,” Acta Psychiatrica Scandinavica, 2016. View at Publisher · View at Google Scholar
  • Dan J. Siskind, Steve Kisely, Janni Leung, Anthony W. Russell, and Daniel Wysoczanski, “Metformin for clozapine associated obesity: A systematic review and meta-analysis,” PLoS ONE, vol. 11, no. 6, 2016. View at Publisher · View at Google Scholar
  • Christoph U. Correll, Lawrence Maayan, John Kane, Marc De Hert, and Dan Cohen, “Efficacy for psychopathology and body weight and safety of topiramate-antipsychotic cotreatment in patients with schizophrenia spectrum disorders: Results from a meta-analysis of randomized controlled trials,” Journal of Clinical Psychiatry, vol. 77, no. 6, pp. e746–e756, 2016. View at Publisher · View at Google Scholar
  • Hasan Bozkurt, and Serkan Sahin, “Weight Loss Associated with Reboxetine Use in Adolescents,” Journal of Child and Adolescent Psychopharmacology, vol. 26, no. 1, pp. 82–83, 2016. View at Publisher · View at Google Scholar
  • P. Chue, and J. Chue, “Antipsychotic Drugs,” 2016. View at Publisher · View at Google Scholar
  • Se Jin Jeon, Eunji Kim, Jin Su Lee, Hee Kyong Oh, Jiabao Zhang, Yubeen Kwon, Dae Sik Jang, and Jong Hoon Ryu, “Maslinic acid ameliorates NMDA receptor blockade-induced schizophrenia-like behaviors in mice,” Neuropharmacology, 2017. View at Publisher · View at Google Scholar
  • Xiao-Jing Gu, Rui Chen, Chen-Hui Sun, Wei Zheng, Xin-Hu Yang, Shi-Bin Wang, Gabor S. Ungvari, Chee H. Ng, Andrei Golenkov, Grace K.I. Lok, Lu Li, Ines H.I. Chow, Fei Wang, and Yu-Tao Xiang, “Effect of adjunctive ranitidine for antipsychotic-induced weight gain: A systematic review of randomized placebo-controlled trials,” Journal of International Medical Research, pp. 030006051771678, 2017. View at Publisher · View at Google Scholar
  • Antonio Bruno, Gianluca Pandolfo, Manuela Crucitti, Antonino Maisano, Rocco A. Zoccali, and Maria Rosaria Anna Muscatello, “Metabolic outcomes of bergamot polyphenolic fraction administration in patients treated with second-generation antipsychotics: a pilot study,” The Journal of Nutritional Biochemistry, vol. 40, pp. 32–35, 2017. View at Publisher · View at Google Scholar
  • Bernard L. Silverman, William Martin, Asli Memisoglu, Lauren DiPetrillo, Christoph U. Correll, and John M. Kane, “A randomized, double-blind, placebo-controlled proof of concept study to evaluate samidorphan in the prevention of olanzapine-induced weight gain in healthy volunteers,” Schizophrenia Research, 2017. View at Publisher · View at Google Scholar
  • Santiago G. Lago, and Sabine Bahn, “Clinical Trials and Therapeutic Rationale for Drug Repurposing in Schizophrenia,” ACS Chemical Neuroscience, 2018. View at Publisher · View at Google Scholar
  • Kah Kheng Goh, Chun-Hsin Chen, and Mong-Liang Lu, “Topiramate mitigates weight gain in antipsychotic-treated patients with schizophrenia: meta-analysis of randomised controlled trials,” International Journal of Psychiatry in Clinical Practice, pp. 1–19, 2018. View at Publisher · View at Google Scholar
  • Paul R L Matthews, Jamie Horder, and Michael Pearce, “Selective noradrenaline reuptake inhibitors for schizophrenia,” Cochrane Database of Systematic Reviews, 2018. View at Publisher · View at Google Scholar